Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada
Sara Carazo, Denis Talbot, Nicole Boulianne, Marc Brisson, Rodica Gilca, Geneviève Deceuninck, Nicholas Brousseau, Mélanie Drolet, Manale Ouakki, Chantal Sauvageau, Sapha Barkati, Elise Fortin, Alex Carignan, Philippe De Wals, Danuta M. Skowronski, Gaston De Serres
doi: https://doi.org/10.1101/2021.07.19.21260445
Sara Carazo
1Centre de Recherche du CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada
Denis Talbot
1Centre de Recherche du CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada
2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
Nicole Boulianne
3Biological and occupational risks. Institut national de sante publique du Quebec, Quebec City, Quebec, Canada
Marc Brisson
1Centre de Recherche du CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada
2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
4Department of Infectious Disease Epidemiology, Imperial College London, UK
Rodica Gilca
1Centre de Recherche du CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada
2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
3Biological and occupational risks. Institut national de sante publique du Quebec, Quebec City, Quebec, Canada
Geneviève Deceuninck
1Centre de Recherche du CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada
Nicholas Brousseau
1Centre de Recherche du CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada
2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
3Biological and occupational risks. Institut national de sante publique du Quebec, Quebec City, Quebec, Canada
Mélanie Drolet
1Centre de Recherche du CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada
Manale Ouakki
3Biological and occupational risks. Institut national de sante publique du Quebec, Quebec City, Quebec, Canada
Chantal Sauvageau
2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
3Biological and occupational risks. Institut national de sante publique du Quebec, Quebec City, Quebec, Canada
Sapha Barkati
5JD MacLean Centre for Tropical Diseases, McGill University Health Centre, McGill University, Montreal, Canada
6Department of Medicine, Division of Infectious Diseases, McGill University Health Center, McGill University, Montreal, Quebec, Canada
Elise Fortin
3Biological and occupational risks. Institut national de sante publique du Quebec, Quebec City, Quebec, Canada
Alex Carignan
7Department of Microbiology and Infectious Diseases, Sherbrooke University, Sherbrooke, Quebec, Canada
Philippe De Wals
2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
3Biological and occupational risks. Institut national de sante publique du Quebec, Quebec City, Quebec, Canada
Danuta M. Skowronski
8Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada
Gaston De Serres
1Centre de Recherche du CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada
2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada
3Biological and occupational risks. Institut national de sante publique du Quebec, Quebec City, Quebec, Canada
Data Availability
Data is not publicly available
Posted July 22, 2021.
Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada
Sara Carazo, Denis Talbot, Nicole Boulianne, Marc Brisson, Rodica Gilca, Geneviève Deceuninck, Nicholas Brousseau, Mélanie Drolet, Manale Ouakki, Chantal Sauvageau, Sapha Barkati, Elise Fortin, Alex Carignan, Philippe De Wals, Danuta M. Skowronski, Gaston De Serres
medRxiv 2021.07.19.21260445; doi: https://doi.org/10.1101/2021.07.19.21260445
Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada
Sara Carazo, Denis Talbot, Nicole Boulianne, Marc Brisson, Rodica Gilca, Geneviève Deceuninck, Nicholas Brousseau, Mélanie Drolet, Manale Ouakki, Chantal Sauvageau, Sapha Barkati, Elise Fortin, Alex Carignan, Philippe De Wals, Danuta M. Skowronski, Gaston De Serres
medRxiv 2021.07.19.21260445; doi: https://doi.org/10.1101/2021.07.19.21260445
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2694)
- Dermatology (229)
- Emergency Medicine (405)
- Epidemiology (12334)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4171)
- Geriatric Medicine (393)
- Health Economics (689)
- Health Informatics (2703)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3954)
- Nursing (214)
- Nutrition (587)
- Oncology (2084)
- Ophthalmology (596)
- Orthopedics (245)
- Otolaryngology (308)
- Pain Medicine (254)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1134)
- Primary Care Research (462)
- Public and Global Health (6593)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (345)
- Surgery (456)
- Toxicology (56)
- Transplantation (191)
- Urology (170)